This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1984:7 Suppl 2:135-6.

doi: 10.1007/978-94-009-5612-4_42.

The antenatal diagnosis and aid to the management of hereditary tyrosinaemia by use of a specific and sensitive GC-MS assay for succinylacetone

B R Pettit, F MacKenzie, G S King, J V Leonard

PMID: 6434868
DOI: 10.1007/978-94-009-5612-4_42

The antenatal diagnosis and aid to the management of hereditary tyrosinaemia by use of a specific and sensitive GC-MS assay for succinylacetone

B R Pettit et al. J Inherit Metab Dis. 1984.

. 1984:7 Suppl 2:135-6.

doi: 10.1007/978-94-009-5612-4_42.

Authors

B R Pettit, F MacKenzie, G S King, J V Leonard

PMID: 6434868
DOI: 10.1007/978-94-009-5612-4_42

No abstract available

PubMed Disclaimer

Similar articles

First-trimester prenatal diagnosis of tyrosinemia type I by amniotic fluid succinylacetone determination.
Jakobs C, Stellaard F, Kvittingen EA, Henderson M, Lilford R. Jakobs C, et al. Prenat Diagn. 1990 Feb;10(2):133-4. doi: 10.1002/pd.1970100210. Prenat Diagn. 1990. PMID: 2343022 No abstract available.
Chemical analysis of succinylacetone and 4-hydroxyphenyllactate in amniotic fluid using selective ion monitoring.
Jakobs C, Sweetman L, Nyhan WL. Jakobs C, et al. Prenat Diagn. 1984 May-Jun;4(3):187-94. doi: 10.1002/pd.1970040305. Prenat Diagn. 1984. PMID: 6463026
Prenatal diagnosis of hereditary tyrosinaemia: measurement of succinylacetone in amniotic fluid.
Gagné R, Lescault A, Grenier A, Laberge C, Mélançon SB, Dallaire L. Gagné R, et al. Prenat Diagn. 1982 Jul;2(3):185-8. doi: 10.1002/pd.1970020307. Prenat Diagn. 1982. PMID: 7145846
Tyrosinaemia type I--an update.
Kvittingen EA. Kvittingen EA. J Inherit Metab Dis. 1991;14(4):554-62. doi: 10.1007/BF01797926. J Inherit Metab Dis. 1991. PMID: 1749221 Review.
Genetic variations in proteins of the amniotic fluid.
Roychoudhury A, Talukder G, Sharma A. Roychoudhury A, et al. Obstet Gynecol Surv. 1978 Oct;33(10):627-40. doi: 10.1097/00006254-197810000-00001. Obstet Gynecol Surv. 1978. PMID: 368692 Review. No abstract available.

See all similar articles

Cited by

Prenatal diagnosis of tyrosinaemia type I by use of stable isotope dilution mass spectrometry.
Jakobs C, Kvittingen EA, Berger R, Haagen A, Kleijer W, Niermeijer M. Jakobs C, et al. Eur J Pediatr. 1985 Jul;144(2):209-10. doi: 10.1007/BF00451920. Eur J Pediatr. 1985. PMID: 4043138 No abstract available.
mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model.
Cacicedo ML, Weinl-Tenbruck C, Frank D, Wirsching S, Straub BK, Hauke J, Okun JG, Horscroft N, Hennermann JB, Zepp F, Chevessier-Tünnesen F, Gehring S. Cacicedo ML, et al. Mol Ther Methods Clin Dev. 2022 Jul 15;26:294-308. doi: 10.1016/j.omtm.2022.07.006. eCollection 2022 Sep 8. Mol Ther Methods Clin Dev. 2022. PMID: 35949297 Free PMC article.
Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
Aponte JL, Sega GA, Hauser LJ, Dhar MS, Withrow CM, Carpenter DA, Rinchik EM, Culiat CT, Johnson DK. Aponte JL, et al. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):641-5. doi: 10.1073/pnas.98.2.641. Proc Natl Acad Sci U S A. 2001. PMID: 11209059 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal